apathy (indifference)
Jump to navigation
Jump to search
Introduction
Indifference. A lack of interest in one's environment, including social interactions.
Etiology
Epidemiology
- most common neurobehavioral symptom in dementia
Pathology
- disruptions of circuits regulating basic drives:
- sexual satisfaction
- food
- curiosity
- pleasure
- disrupted circuits include
- mesolimbic system
- mesocortical dopaminergic circuits
Clinical manifestations
- reduction in psychomotor activity
- often perceived as a personality change by family
- affects ADLs beyond the level of cognitive impairment
- suspicion of other residents & staff may be present[3]
- appearance of sadness at times may be present[3]
- appetite, weight, & sleep patterns may be unchanged[3]
Diagnostic criteria
- Association Francaise de Psychiatrie Biologique (AFPB) & European Psychiatric Association (EPA) task force criteria for apathy in Alzheimer disease & other neuropsychiatric disorders
- presence of quantitative reduction of goal-directed activity either in the behavioral, cognitive, emotional or social dimension in comparison to the patient's previous level of functioning
- minimum duration of 4 weeks
- symptoms need to present in 2 or 3 domains
- functional impairment
- not explained by or due to major changes in the patient's environment[3]
Complications
- associated with a faster rate of cognitive decline & functional decline in Alzheimer disease
Management
- little evidence to support specific therapy[3][4]
- cholinesterase inhibitors may be of some benefit[4]
- methylphenidate may be of benefit in community-dwelling elderly with mild to moderate Alzheimer's disease[5][6]
- may improve motivation, cognition, mood, functioning, & caregiver burden
- does not affect patients' function or quality of life[6]
More general terms
References
- ↑ Stedman's Medical Dictionary 27th ed, Williams & Wilkins, Baltimore, 1999
- ↑ Principles of Neurology, 4th ed, Adams RD & Victor M (eds) McGraw-Hill, Inc, New York, 1989
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022 - ↑ 4.0 4.1 4.2 Berman K, Brodaty H, Withall A, Seeher K Pharmacologic treatment of apathy in dementia. Am J Geriatr Psychiatry. 2012 Feb;20(2):104-22. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21841459
- ↑ 5.0 5.1 Padala PR, Padala KP, Lensing SY et al. Methylphenidate for apathy in community-dwelling older veterans with mild Alzheimer's disease: A double-blind, randomized, placebo-controlled trial. Am J Psychiatry 2017 Sep 15 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28945120
- ↑ 6.0 6.1 6.2 George J Stimulant Reduces Apathy in Alzheimer's Disease Twice daily methylphenidate showed modest effect size. MedPage Today September 27, 2021 https://www.medpagetoday.com/neurology/alzheimersdisease/94722
Mintzer J, Lanctot KL, Scherer RW et al Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease. The ADMET 2 Randomized Clinical Trial. JAMA Neurol. Published online September 27, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34570180 https://jamanetwork.com/journals/jamaneurology/fullarticle/2784538
Fredericks C Methylphenidate for Apathy in Alzheimer Disease - Why Should We Care? JAMA Neurol. Published online September 27, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34570178 https://jamanetwork.com/journals/jamaneurology/fullarticle/2784541 - ↑ Robert P, Lanctot KL, Aguera-Ortiz L et al. Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur Psychiatry. 2018;54:71-76 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30125783 Free article https://www.cambridge.org/core/journals/european-psychiatry/article/is-it-time-to-revise-the-diagnostic-criteria-for-apathy-in-brain-disorders-the-2018-international-consensus-group/5A3A2F39C4A322DCCAD6B044B4AF5CB1